Advertisement NanoString unveils nCounter human karyotype panel - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

NanoString unveils nCounter human karyotype panel

NanoString Technologies has unveiled fixed-panel multiplexed assay kit, the nCounter Human Karyotype Panel, used to monitor cell line quality, perform cytogenetics research.

The nCounter analysis system is a fully automated digital detection and counting system with a simple workflow which measures chromosome number and detect aneuploidy.

Chief commercial officer Barney Saunders said they continue to demonstrate the extensibility of nCounter platform with a range of applications that address important market needs.

"With the introduction of the Human Karyotype Panel, NanoString is making molecular karyotyping accessible to anyone interested in monitoring cell line integrity and removing the bottleneck in the quality control process," Saunders said.